Cargando…

The cyclophilin inhibitor CRV431 prevents both cyclophilin A-HBx complex formation and HBV replication

Detalles Bibliográficos
Autores principales:	Foster, R.T., Ure, D.R., Trepanier, D.J., Gallay, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172068/ http://dx.doi.org/10.1016/S0168-8278(17)31875-5

Ejemplares similares

The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
por: Gallay, Philippe, et al.
Publicado: (2019)

A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease Models
por: Kuo, Joseph, et al.
Publicado: (2019)

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action
por: Gallay, Philippe A., et al.
Publicado: (2015)

In Vitro Phase I Metabolism of CRV431, a Novel Oral Drug Candidate for Chronic Hepatitis B
por: Trepanier, Daniel J., et al.
Publicado: (2017)

Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice
por: Bobardt, Michael, et al.
Publicado: (2020)

Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B
por: Tanaka, Yoshikazu, et al.
Publicado: (2017)

Cyclophilins and cyclophilin inhibitors in nidovirus replication
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity
por: Stauffer, Winston, et al.
Publicado: (2023)

Cyclophilins as Modulators of Viral Replication
por: Frausto, Stephen D., et al.
Publicado: (2013)

The cyclophilins
por: Wang, Ping, et al.
Publicado: (2005)

Cyclophilin
Publicado: (2011)

Suppression of Coronavirus Replication by Cyclophilin Inhibitors
por: Tanaka, Yoshikazu, et al.
Publicado: (2013)

The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance
por: Bobardt, Michael, et al.
Publicado: (2021)

Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells
por: Bobardt, Michael, et al.
Publicado: (2014)

Cyclophilin B facilitates the replication of Orf virus
por: Zhao, Kui, et al.
Publicado: (2017)

Curing a viral infection by targeting the host: The example of cyclophilin inhibitors
por: Lin, Kai, et al.
Publicado: (2013)

Cyclophilin Inhibitors: An Emerging Class of Therapeutics for the Treatment of Chronic Hepatitis C Infection
por: Hopkins, Sam, et al.
Publicado: (2012)

Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single‐blind, placebo‐controlled study in F2/F3 NASH
por: Harrison, Stephen A., et al.
Publicado: (2022)

Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175
por: Gallay, Philippe A., et al.
Publicado: (2016)

Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture
por: de Wilde, Adriaan H., et al.
Publicado: (2018)

Microglia are both a source and target of extracellular cyclophilin A
por: Flora, Gurkiran Kaur, et al.
Publicado: (2019)

Chicken cyclophilin A is an inhibitory factor to influenza virus replication
por: Xu, Chongfeng, et al.
Publicado: (2010)

Cyclophilin and Viruses: Cyclophilin as a Cofactor for Viral Infection and Possible Anti-Viral Target
por: Watashi, Koichi, et al.
Publicado: (2007)

Cyclophilins: Proteins in search of function
por: Kumari, Sumita, et al.
Publicado: (2013)

Extracellular cyclophilins in health and disease()
por: Bukrinsky, Michael
Publicado: (2015)

Cyclophilin polymorphism and virus infection
por: von Hahn, Thomas, et al.
Publicado: (2015)

Cyclophilin A and viral infections
por: Zhou, Daijun, et al.
Publicado: (2012)

Cyclophilin inhibitors as antiviral agents
por: Peel, Michael, et al.
Publicado: (2013)

Non‐Immunosuppressive Cyclophilin Inhibitors
por: Schiene‐Fischer, Cordelia, et al.
Publicado: (2022)

Recombinant Human Cyclophilin A in vitro Inhibits the Formation of Fibrin Clot 
por: Morozov, Yu.A., et al.
Publicado: (2012)

Functional analysis of Leishmania major cyclophilin
por: Yurchenko, Vyacheslav, et al.
Publicado: (2008)

Current implications of cyclophilins in human cancers
por: Lee, Jinhwa, et al.
Publicado: (2010)

Cyclophilin D: An Integrator of Mitochondrial Function
por: Amanakis, Georgios, et al.
Publicado: (2020)

Human cyclophilin 40 unravels neurotoxic amyloids
por: Baker, Jeremy D., et al.
Publicado: (2017)

CUL4B facilitates HBV replication by promoting HBx stabilization
por: Shan, Haixia, et al.
Publicado: (2022)

Cyclophilin E Functions as a Negative Regulator to Influenza Virus Replication by Impairing the Formation of the Viral Ribonucleoprotein Complex
por: Wang, Zengfu, et al.
Publicado: (2011)

Bioengineering and Semisynthesis of an Optimized Cyclophilin Inhibitor for Treatment of Chronic Viral Infection
por: Hansson, Magnus Joakim, et al.
Publicado: (2015)

Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma
por: Simón Serrano, Sonia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlq2maqpbergbh8e7p4r0gss9i